Flow Pharma
Warrensville Heights, US · Delaware corporation · 1 known investors
Find your way into Flow Pharma
Sign up to see every warm intro you have to Flow Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Flow Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Flow Pharma is a biotechnology company developing therapeutics, with work spanning bioinformatics and neuro-oncology, cancer risk assessment, and immunotherapy research. The page is an advisors listing describing the company's scientific and medical advisory board members.
Founders & leadership

Board
Investors · 1
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$3.8M disclosed across 4 of 5 rounds · 2011–2024
- Undisclosed amountSeed RoundSep 2018
Button Capital
Source ↗
▶$225KraisedAug 2024 · 3 investors · BiotechnologyRule 506(b)
- Pamela SteeleDirector
- Anthony TufaroDirector
- Reid Martin RubsamenExecutive Officer, Director
- Tikoes BlankenbergDirector
- Babatunde OtulanaDirector
- Offering amount
- $40M
- Amount sold
- $225K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$180KraisedNov 2022 · 8 investors · BiotechnologyRule 506(c)
- Gil Van BokkelenExecutive Officer
- Reid Martin RubsamenExecutive Officer, Director
- Tikoes BlankenbergDirector
- Thomas BarnishExecutive Officer
- Stephen FarrDirector
- Charles Vincent HerstExecutive Officer
- Tom BradyExecutive Officer
- Pamela SteeleDirector
- Babatunde OtulanaDirector
- Offering amount
- $10.5M
- Amount sold
- $180K
- Finders' fees
- $500K
- Placement agents
- Carleton McKenna Advisors, LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$2.3MraisedFeb 2018 · 42 investors · BiotechnologyRule 506(b)
- Reid Michael RubsamenExecutive Officer, Director
- Thomas BradyExecutive Officer
- Lester John LloydExecutive Officer, Director
- Amount sold
- $2.3M
- Minimum investment
- $5K
- Proceeds to insiders
- $300K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2018 · 17 investors · BiotechnologyRule 506(b)
- Reid M RubsamenExecutive Officer, Director
- Lester J LloydExecutive Officer, Director
- Amount sold
- $1.1M
- Minimum investment
- $12.5K
- First sale
- Apr 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Flow Pharma.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseOffice for Chemical and Biological Defense | Phase IISTTR | 2020 | $537.5K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase ISTTR | 2018 | $136.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Flow Pharma do?
- Flow Pharma is a biotechnology company developing therapeutics, with work spanning bioinformatics and neuro-oncology, cancer risk assessment, and immunotherapy research. The page is an advisors listing describing the company's scientific and medical advisory board members.
- Who founded Flow Pharma?
- Flow Pharma was founded by Reid Martin Rubsamen, Reid Michael Rubsamen.
- How much funding has Flow Pharma raised?
- Flow Pharma has disclosed $3.8M raised across 4 of its 5 known rounds.
- Where is Flow Pharma headquartered?
- Flow Pharma is headquartered in Warrensville Heights, US.


